EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica

• Rana El Hajj,

  Roles Methodology, Writing – original draft

  Affiliation Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon

  http://orcid.org/0000-0001-9125-5137

  ⨯
• Hanady Bou Youness,

  Roles Methodology

  Affiliation Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon

  ⨯
• Laurence Lachaud,

  Roles Methodology

  Affiliation Centre Hospitalo-Universitaire, Université de Montpellier, Montpellier, France

  ⨯
• Patrick Bastien,

  Roles Methodology

  Affiliation Centre Hospitalo-Universitaire, Université de Montpellier, Montpellier, France

  ⨯
• Carine Masquefa,

  Roles Methodology

  Affiliation Faculté de Pharmacie, Université de Montpellier, Montpellier, France

  ⨯
• Pierre-Antoine Bonnet,

  Roles Methodology

  Affiliation Faculté de Pharmacie, Université de Montpellier, Montpellier, France

  ⨯
• Hiba El Hajj ,

  Contributed equally to this work with: Hiba El Hajj, Ibrahim Khalifeh

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – review & editing

  * E-mail: he21@aub.edu.lb (HEH); ik08@aub.edu.lb (IK)

  Affiliation Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon

  http://orcid.org/0000-0002-1069-0477

  ⨯
• Ibrahim Khalifeh

  Contributed equally to this work with: Hiba El Hajj, Ibrahim Khalifeh

  Roles Funding acquisition, Methodology, Project administration, Validation

  * E-mail: he21@aub.edu.lb (HEH); ik08@aub.edu.lb (IK)

  Affiliation Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon

  ⨯